Sartorius Stedim Biotech Stock OTC Markets
Equities
SDMHF
FR0013154002
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
176.2 USD | +0.69% |
|
0.00% | -33.19% |
07-10 | Markets Powered by Alternating Current | ![]() |
07-09 | Mixed feelings | ![]() |
Sales 2024 * | 2.9B 3.17B 4.33B | Sales 2025 * | 3.25B 3.55B 4.86B | Capitalization | 16.87B 18.44B 25.22B |
---|---|---|---|---|---|
Net income 2024 * | 302M 330M 451M | Net income 2025 * | 417M 456M 623M | EV / Sales 2024 * | 6.61 x |
Net Debt 2024 * | 2.27B 2.48B 3.39B | Net Debt 2025 * | 2.17B 2.37B 3.24B | EV / Sales 2025 * | 5.86 x |
P/E ratio 2024 * |
52.3
x | P/E ratio 2025 * |
37.2
x | Employees | 10,493 |
Yield 2024 * |
0.42% | Yield 2025 * |
0.52% | Free-Float | 31.97% |
Latest transcript on Sartorius Stedim Biotech
1 day | +0.69% | ||
Current month | +6.79% | ||
1 month | -7.26% | ||
3 months | -34.74% | ||
6 months | -27.19% | ||
Current year | -33.19% |
![Extreme 158](/images/extremecours_fleche.png)
![Extreme 158](/images/extremecours_fleche.png)
![Extreme 158](/images/extremecours_fleche.png)
![Extreme 158](/images/extremecours_fleche.png)
![Extreme 135.55](/images/extremecours_fleche.png)
![Extreme 60.06](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 49 | 19-03-25 |
Chairman | 59 | 07-06-28 | |
Chief Tech/Sci/R&D Officer | 59 | 09-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 07-06-28 |
Chairman | 59 | 07-06-28 | |
Susan Dexter
BRD | Director/Board Member | 67 | 15-04-06 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.90% | 182B | |
-1.36% | 104B | |
-7.64% | 45.58B | |
+9.30% | 46.44B | |
+9.63% | 44.34B | |
+13.63% | 29.44B | |
+20.29% | 26.8B | |
-7.12% | 23.82B | |
+4.03% | 22.61B |
- Stock Market
- Equities
- DIM Stock
- SDMHF Stock